Ohmori K, Suzuki M, Endo S, Watanabe I, Endo S
Jpn J Antibiot. 1983 Jul;36(7):1593-8.
Micronomicin (MCR, Sagamicin), a new derivative of aminoglycoside, was used in 9 patients with postoperative infection mainly caused by Gram-negative bacilli. A dose of 60-120 mg was intramuscularly administered continuously twice a day for 3-21 days. The therapeutic results were excellent in 2, good in 3, fair in 1 and poor in 2 cases. The assessment was impossible in 1 patient. The effective rate was 62.5%. No side effects were encountered in any cases.
小诺米星（MCR，沙加霉素），一种氨基糖苷类新衍生物，用于9例主要由革兰氏阴性杆菌引起的术后感染患者。剂量为60 - 120毫克，每日两次连续肌肉注射，疗程3 - 21天。治疗结果为优2例，良3例，中1例，差2例。1例患者无法评估。有效率为62.5%。所有病例均未出现副作用。
